Table of Contents
From the Editor
- Old drug, new data, continued vigilance
Colchicine, an old and familiar drug for gout, has found another use in preventing and treating pericarditis. But familiarity should not dampen vigilance.
Review
- Parkinson disease: Managing a complex, progressive disease at all stages
Parkinson disease is complex to manage. Its presentation can vary, as can its response to treatment. Physicians tend to focus on its motor symptoms, but many patients find nonmotor symptoms equally troublesome.
In vitro fertilization updateThe science of in vitro fertilization has improved considerably in the last 25 years. We provide an overview of the current and experimental techniques of assisted reproductive technology.
- Anabolic steroid abuse: Psychiatric and physical costs
Anabolic-androgenic steroid abuse is no longer confined to professional athletes. Physicians should be aware of its signs and symptoms so that they can address its adverse effects and treat it.
Medical Grand Rounds
- Viral infections and the kidney: HIV, hepatitis B, and hepatitis C
Ten years ago, viral glomerulonephritis was usually regarded as untreatable. Now treatments are available for the top three causes: HIV, hepatitis B, and hepatitis C.
Imaging in Practice
- Intravenous iodinated contrast agents: Risks and problematic situations
Many diagnostic imaging studies use intravenous contrast media. Although these agents are generally safe, they do pose some risk of adverse reactions.
Current Drug Therapy
- Newer hormonal therapies: Lower doses; oral, transdermal, and vaginal formulations
We review some of the hormonal regimens that have been approved in the past 5 years.
Im Board Review
- Neurologic effects of hyponatremia and its treatment
Twenty-one days after surviving a hemorrhagic stroke, the patient develops new neurologic symptoms. A computed tomographic scan shows new cerebral edema. Her serum sodium concentration is 121 mmol/L.
1-Minute Consult
- Should all patients with acute pericarditis be treated with colchicine?
Colchicine should be considered a first-line treatment for acute pericarditis and for preventing recurrent episodes.
